US FDA alerts health care providers of recall of anemia drug Omontys – In US, Omontys Injection is recalled due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients. Until further notice, health care providers should stop using Omontys.
U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent
The U.S. Food and Drug Administration approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in
Farm Antibiotics May Be Linked to Food Allergies — Some food allergies may be connected to pesticides – People with food allergies always have to watch what they eat. Now, they may have to watch what their fruits and vegetables eat, as it seems it’s possible to have an allergic reaction to antibiotic residues in food.
FDA takes action against thousands of illegal Internet pharmacies — Agency participates in international Operation Pangea V to protect consumers from potentially dangerous, unapproved drugs – The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action this week against more than 4,100 Internet pharmacies that illegally sell potentially dangerous, unapproved drugs to consumers. Actions taken include civil and criminal charges, seizure of illegal products, and removal of offending websites.
NIH-sponsored panel issues comprehensive US food allergy guidelines — Guidelines recommend uniform standards in the diagnosis and management of food allergy – An expert panel sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has issued comprehensive U.S. guidelines to assist health care professionals in diagnosing food allergy and managing the care of people with the disease.
FDA Approves Kalbitor for Treating Potentially Life-Threatening Attacks of Hereditary Angioedema – The U.S. Food and Drug Administration approved Kalbitor (ecallantide) to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE).
Allergic reactions to food can range from mild, itchy hives to anaphylaxis, the most severe reaction. Standardized clinical guidelines will help healthcare providers better diagnose food allergy, manage ongoing food allergy and treat acute food allergy reactions. – This week, May 10-16, marks Food Allergy Awareness Week, a time to focus public awareness on this growing health problem. Together with the Food Allergy and Anaphylaxis Network (FAAN), a patient and family advocacy group at the National Institute of Allergy and Infectious Diseases (NIAID) encourage all Americans to help those affected by this life-limiting disease.
Scientists developing food allergy treatment, hoping for a cure that will allow people to eat fish or fruit again. – A team of scientists from across Europe are embarking on new research to develop a treatment for food allergy.
Allergy and immunology consultant Liew Woei Kang and colleagues found that true hypersensitivity to the quadrivalent human papillomavirus vaccine was uncommon, and most girls in Australian schools tolerated subsequent doses. – Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj.com.
